Melanoma trials in Israel

In Israel 13 Also abroad 579

13 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Beersheba, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
Phase 2Taking people
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Where
Afula, Jerusalem, Petah Tikva, Ramat Gan
Age
18 years and over
People
160 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06961006
Phase 3Taking people
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Where
Jerusalem, Ramat Gan, Tel Aviv
Age
18 years to 70 years
People
670 worldwide
Run by
Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00
Phase 1/2Taking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Haifa, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
1,109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
Phase 1/2Taking people
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Where
Hod HaSharon
Age
6 months to 17 years
People
370 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00
No phaseTaking people
The Multicentre Selective Lymphadenectomy Trial - 3
Where
Ramat Gan
Age
18 years and over
People
1,500 worldwide
Run by
Melanoma Institute Australia
See details and how to joinNCT07049276
Phase 3Taking people
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Where
Jerusalem, Ramat Gan
Age
18 years and over
People
520 worldwide
Run by
IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00
Phase 1/2Taking people
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
Where
Jerusalem
Age
18 years and over
People
50
Run by
Hadassah Medical Organization
See details and how to joinNCT00722228
Phase 1/2Taking people
Modified Vaccine for High Risk or Low Residual Melanoma Patients
Where
Jerusalem
People
50
Run by
Hadassah Medical Organization
See details and how to joinNCT01898039
Phase 1/2Taking people
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Where
Jerusalem
Age
18 years to 70 years
People
3
Run by
Hadassah Medical Organization
See details and how to joinNCT05296564
Phase 2Taking people
Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
Where
Ramat Gan
Age
18 years and over
People
33
Run by
Sheba Medical Center
See details and how to joinNCT05909618
Phase 1/2Not yet taking people in Israel
Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.
Where
Petah Tikva
Age
18 years to 100 years
People
60
Run by
Rabin Medical Center
See details and how to joinNCT06896552
No phaseTaking people
Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
Where
Jerusalem
People
250
Run by
Hadassah Medical Organization
See details and how to joinNCT01438658